Grab your favorite coffee. This is where you’ll find all the substance you require, and more.
Introducing Cognivia Signal: Early-Warning Behavioral Risk Intelligence for Clinical Trials
Cognivia launches the world’s first early-warning behavioral risk intelligence dashboard—Cognivia Signal—empowering clinical teams to see what’s coming before it happens. Mont-Saint-Guibert, Belgium – October 9, 2025 – Cognivia,…
How to Use ePRO to Understand the Impact of Decentralized Clinical Trials on Patients
In this article, we will first discuss the rise of DCTs, empowered by technology like ePRO in clinical trials. Then, we will review how related technology can…
Should placebo responders be excluded from RCTs?
Scientific Poster presented on September 2021 at the International Society for CNS Clinical Trial and Methodology Conference The…
Getting New Pain Drugs to Market: 3 Challenges
Each September, pain advocates and specialists raise awareness about issues facing the millions of people living with chronic pain. One of the most pressing? The lack of treatments available to alleviate suffering.…
How much of the measured treatment response in clinical trials is due to the placebo response?
Clinical trials measure efficacy of experimental therapies by comparing outcomes in patients receiving therapeutic interventions (treatment response) with patients receiving placebo (placebo response).
Video Presentation – Towards an automated rating of the MDS-UPDRS motor scores
Scientific poster presented on September 2021 at the International Parkinson and Movement Disorder Society Annual Conference.
Video Presentation – Modeling of the Placebo Response in Parkinson’s Disease
Scientific Poster presented on September 2021 at the International Parkinson and Movement Disorder Society Annuel Meeting.
Understand patient differences in your next clinical trial
Increase your trial’s success rates and bring new therapies to patients faster.
Tell us about your clinical trial below, and our team will be in touch.
"*" indicates required fields